PKM and neoplasm: Simultaneously, PKM2 acts as a transcriptional coactivator of hypoxia inducible factor 1 - α (HIF1 α) and upregulates its expression, thus increasing the expression of MCT4 and sensitizing the glycolytic activity of tumor cells 19-21.